Rob Dillard

DocwireNews

<h2>More than 95% of People in These Nations Have Yet to be Vaccinated<p>At least 15 countries around the world <a href="https://www.cnn.com/us/live-news/coronavirus-pandemic-vaccine-updates-09-24-21/index.html">have yet</a> to administer at least one vaccine dose to more than 3% of their population. Among them are Nigeria, Africa&rsquo;s most populous nation with more than 200 million people, and Ethiopia with around 115 million people, as well as&nbsp;<a href="https://www.cnn.com/2021/09/23/americas/haitian-kids-deportees-intl-latam/index.html" target="_blank" rel="noopener noreferrer">Haiti</a>, only about 700 miles from the US state of Florida.</p><h2><a href="https://www.docwirenews.com/docwire-pick/fda-approves-pfizer-booster-shots-for-seniors-high-risk-americans/">FDA Approves Pfizer Booster Shots for Seniors, High-Risk Americans</a></h2><p>The U.S. Food and Drug Administration on Wednesday approved Pfizer booster shots for people over 65 and for those at high risk of severe COVID-19. &ldquo;Today&rsquo;s action demonstrates that science and the currently available data continue to guide the FDA&rsquo;s decision-making for COVID-19 vaccines during this pandemic,&rdquo; Acting FDA Commissioner Dr. Janet Woodcock said in an agency news release.</p><h2>CDC Recommends COVID Boosters for Some Americans</h2><p>After much debate, booster shots of the Pfizer/BioNTech COVID-10 vaccine can now be administered to some US adults, <a href="https://www.cnn.com/us/live-news/coronavirus-pandemic-vaccine-updates-09-24-21/index.html">per a</a> CNN report. CDC Director Dr. Rochelle Walensky recommended boosters for a broader group of people &ndash; those ages t 64 who are at increased risk of COVID-19 due to their workplaces or institutional settings &ndash; in addition to older adults, long-term care facility residents and some people with underlying health conditions.</p><h2>Antibodies to Early Strains of COVID May Not Fight New Variants: Study</h2><p>Antibodies from current COVID-19 vaccines don&rsquo;t bind well to the new variants of the virus, a study finds. Researchers collected data from previously published papers about the sequence of antibodies produced by the vaccines. They focused on antibodies against the spike protein, a part of the virus that binds to receptors on human cells to infect them. It&rsquo;s the target of most vaccines. &ldquo;Even though this antibody response is very common with the original strain, it doesn&rsquo;t really interact with variants,&rdquo; Wu said. &ldquo;That, of course, raises the concern of the virus evolving to escape the body&rsquo;s main antibody response. Some antibodies should still be effective &mdash; the body makes antibodies to many parts of the virus, not only the spike protein &mdash; but the particular groups of antibodies that we saw in this study will not be as effective.&rdquo;</p><p>&nbsp;</p></h2>


MarkAlain Déry, DO

The Significant Danger Measles Pose for Unvaccinated Children

Infectious Disease

Andrew Moreno

Antithrombotic Care in Hemophilia: A Summary of Multi-Organizational Clinical Practice Guidance

Hemophilia

James Tumlin, MD

Joel M. Topf, MD, FACP

Proteinuria Remission With Sparsentan in FSGS

NKF Spring Clinical Meetings 2025

Latest News

COVID-19 Round-Up: CDC Recommends Boosters for Some Americans; and More

COVID-19

More than 95% of People in These Nations Have Yet to be Vaccinated ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HER2 Breast Cancer

HR Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe